Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction

Translation of High-Density Lipoprotein Function Into Clinical Practice

(2018) Robert S. Rosenson et al.   CIRCULATION

Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles

(2015) Mike Mackness et al.   GENE

Network-Based Analysis on Orthogonal Separation of Human Plasma Uncovers Distinct High Density Lipoprotein Complexes

(2015) Hailong Li et al.   JOURNAL OF PROTEOME RESEARCH

The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity

(2015) Duygu Sag et al.   Nature Communications

Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease

(2015) Chiz-Tzung Chang et al.   Biomed Research International

Regulation of High-Density Lipoprotein Metabolism

(2014) Kerry-Anne Rye et al.   CIRCULATION RESEARCH

HDL and cardiovascular disease

(2014) Daniel J Rader et al.   LANCET

An abundant dysfunctional apolipoprotein A1 in human atheroma

(2014) Ying Huang et al.   NATURE MEDICINE

Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology

(2014) Ruth Birner-Gruenberger et al.   PROGRESS IN LIPID RESEARCH

HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells

(2014) Fatiha Tabet et al.   Nature Communications

The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects

(2013) Maryam Zamanian-Daryoush et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex

(2013) Ying Huang et al.   JOURNAL OF CLINICAL INVESTIGATION

High-density lipoproteins: A consensus statement from the National Lipid Association

(2013) Peter P. Toth et al.   Journal of Clinical Lipidology

HDL and cholesterol: life after the divorce?

(2013) Kasey C. Vickers et al.   JOURNAL OF LIPID RESEARCH

Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond

(2013) Amy S. Shah et al.   JOURNAL OF LIPID RESEARCH

Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells

(2013) Jonathan J Hulce et al.   NATURE METHODS

Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Chronic Kidney Disease

(2013) D. J. Kennedy et al.   Journal of the American Heart Association

High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport

(2012) Edward A. Fisher et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk

(2012) W.H. Wilson Tang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High Density Lipoprotein Biogenesis, Cholesterol Efflux, and Immune Cell Function

(2012) Mary G. Sorci-Thomas et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cholesterol Efflux and Atheroprotection

(2012) Robert S. Rosenson et al.   CIRCULATION

Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity

(2012) Manojkumar Valiyaveettil et al.   TOXICOLOGY LETTERS

Exploiting Bioorthogonal Chemistry to Elucidate Protein–Lipid Binding Interactions and Other Biological Roles of Phospholipids

(2011) Michael D. Best et al.   ACCOUNTS OF CHEMICAL RESEARCH

The HDL proteome in acute coronary syndromes shifts to an inflammatory profile

(2011) Khalid Alwaili et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

An1O2Route to γ-Hydroxyalkenal Phospholipids by Vitamin E-Induced Fragmentation of Hydroperoxydiene-Derived Endoperoxides

(2011) Xiaodong Gu et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Aliphatic Diazirines as Photoaffinity Probes for Proteins: Recent Developments

(2011) Joydip Das   CHEMICAL REVIEWS

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

(2011) Christian Besler et al.   JOURNAL OF CLINICAL INVESTIGATION

Association between PON1 activity and coronary heart disease risk: A meta-analysis based on 43 studies

(2011) Yuan Zhao et al.   MOLECULAR GENETICS AND METABOLISM

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

(2011) Kasey C. Vickers et al.   NATURE CELL BIOLOGY

Diminished Antioxidant Activity of High-Density Lipoprotein–Associated Proteins in Systolic Heart Failure

(2010) W.H. Wilson Tang et al.   Circulation-Heart Failure

Proteomic Characterization of Human Plasma High Density Lipoprotein Fractionated by Gel Filtration Chromatography

(2010) Scott M. Gordon et al.   JOURNAL OF PROTEOME RESEARCH

Imaging the Lipidome: ω-Alkynyl Fatty Acids for Detection and Cellular Visualization of Lipid-Modified Proteins

(2009) Rami N. Hannoush et al.   ACS Chemical Biology

Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters

(2009) W. Sean Davidson et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Double Superhelix Model of High Density Lipoprotein

(2009) Zhiping Wu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular Risk

(2008) Tamali Bhattacharyya   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Myeloperoxidase, modified lipoproteins, and atherogenesis: Fig. 1.

(2008) Stephen J. Nicholls et al.   JOURNAL OF LIPID RESEARCH

Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning

(2008) R. C. Stevens et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA